GLP-1 drugs and pharma marketing: what the critics get right and wrong

What did @heal.with.fifi actually say?

The creator's core argument is that GLP-1 marketing is "so disempowering" because it tells people "you couldn't possibly lose weight on your own." She's not calling for banning these drugs. She's calling out the messaging around them, and she extends the same criticism to the wellness industry selling $800 red lights and $7,000 saunas. Her claim that fasting can stimulate endogenous GLP-1 production is the most specific scientific assertion she makes, and it's worth examining separately.

She also cites the "80% of people who diet gain all the weight back" statistic to argue that this failure rate is used to push medication rather than improve nutrition education. And she suggests that fasting is a free, accessible tool that doesn't get promoted because "there's no money in it."

Does the science back this up?

Partially, yes. The claim that dietary changes and fasting can raise endogenous GLP-1 levels is real but often overstated on social media. Protein-rich meals, fermented foods, and certain dietary fibers do stimulate L-cell secretion of GLP-1 in the gut (Holst, 2007, Physiological Reviews). Intermittent fasting has also been shown to modestly improve GLP-1 response in some studies (Catenacci et al., 2016, Obesity). However, the magnitude of these effects is nowhere near the sustained pharmacological levels achieved by semaglutide or tirzepatide. Endogenous GLP-1 has a half-life of roughly two minutes before degradation. Drug formulations are engineered specifically to resist that breakdown.

The "80% regain" figure is a real pattern in obesity research, though the exact percentage varies by study. A 2020 analysis in the New England Journal of Medicine reviewing long-term weight loss data found that most people regain a significant portion of lost weight within five years without ongoing behavioral support. Using this to argue against medication rather than in favor of better post-diet support is where her logic gets selective.

What did they get wrong (or right)?

She's right that pharmaceutical and wellness marketing both exploit the same psychological lever: the idea that you are broken without this product. That critique is legitimate and underreported. Researchers in health communication have documented that direct-to-consumer advertising for chronic disease medications can reduce perceived personal agency (Frosch et al., 2011, Annals of Family Medicine). Credit where it's due.

Where she stumbles is in implying that lifestyle interventions are broadly sufficient alternatives for conditions like type 2 diabetes or severe obesity. For people with a BMI over 40, or those who have already cycled through years of dietary attempts, "you have everything you need within you" isn't just optimistic, it can be genuinely harmful framing. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide producing an average 14.9% body weight reduction, which exceeds what most lifestyle interventions achieve in head-to-head comparisons. Her counter-framing risks mirroring the exact disempowerment she criticizes, just pointed in the opposite direction.

Her claim that "there's no money" in promoting free lifestyle tools also ignores that she is a paid nutritional therapist. There is a business model there.

What should you actually know?

GLP-1 receptor agonists are not a cure, and the creator is correct that stopping medication often leads to weight regain. A 2022 withdrawal study (Wilding et al., NEJM Evidence) found participants regained two-thirds of lost weight within a year of stopping semaglutide without continued behavioral support. That data actually argues for pairing medication with nutrition education, not choosing one over the other.

Fasting and protein intake do stimulate some endogenous GLP-1 release, but the physiological effect is modest and short-lived compared to medication. It is not a like-for-like substitute for someone with severe insulin resistance or obesity-related comorbidities.

If you're considering any GLP-1 medication, or trying to manage weight or metabolic health through lifestyle alone, the most evidence-based path involves working with a licensed clinician who can assess your individual situation, not a TikTok video in either direction.